Premium
Kinetics of indocyanine green removal from blood can be used to predict the size of the area removed by radiofrequency ablation of hepatic nodules
Author(s) -
Sato Shuichi,
Miyake Tatsuya,
Mishiro Tomoko,
Furuta Kohichiro,
Azumi Takane,
Oshima Naoki,
Takahashi Yoshiko,
Rumi Mohammad A.K.,
Ishihara Shunnji,
Adachi Kyoichi,
Amano Yuji,
Kinoshita Yoshikazu
Publication year - 2006
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/j.1440-1746.2006.04417.x
Subject(s) - indocyanine green , medicine , radiofrequency ablation , hepatocellular carcinoma , ablation , blood flow , nuclear medicine , ablation zone , vein , radiology , surgery
Abstract Background and Aim: The size of radiofrequency ablation (RFA) in the liver can be negatively influenced by the surrounding blood flow. The indocyanine green (ICG) test can be used to evaluate the effective blood flow in the liver, and distance from the hilus can affect local blood flow. The aim of this study was to assess whether the ICG test or distance from the hilus could be used to predict the size of the ablated area in liver by RFA treatment of hepatocellular carcinoma (HCC) nodules. Methods: The RFA measurements of 44 HCC nodules in 39 patients were retrospectively studied. Cases were included if they met the following criteria: (i) no catheter treatment before RFA; (ii) no movement of the RFA device; (iii) strict ablation time; and (iv) only one ablation. In all patients, ICG‐R15 testing was done immediately before RFA and the initial therapeutic efficacy was evaluated by dynamic computed tomography scanning 2–5 days after RFA. The correlation between the maximum size of the RFA area and the ICG test results or the distance of the target area from the hilus (site of first portal vein divergence) were analyzed statistically. Results: The ICG‐R15 result was significantly correlated with the maximum diameter of the ablated area both in 2 cm‐electrode tip length ( R 2 = 0.35, P = 0.0012), and in 3 cm‐tip length ( R 2 = 0.26, P = 0.0377). Multiple‐regression analysis showed that the electrode tip length ( P = 0.0010) and ICG‐R15 ( P = 0.0046) were independent factors that could predict the maximum diameter of the RFA area. Conclusion: The results of ICG testing can be used to predict the size of the area that will be ablated at a target liver site before RFA treatment.